📋 Tender Overview
The subject of this publication is the conclusion of agreements according to § 130a Abs.8 SGB V for various active ingredients/active ingredient combinations within the framework of a so-called Open House procedure. Under the provision of uniform contract conditions and a uniform access procedure, all suitable and interested pharmaceutical companies or communities of pharmaceutical companies are offered the conclusion or accession to a discount contract according to § 130a Abs. 8 SGB V for the mentioned active ingredient/active ingredient combination. Brivaracetam, Teduglutid, Testosterone (only gel)